Browsing Tag
DOC1021
1 post
Can Diakonos make personalized melanoma cell therapy work without toxic conditioning?
Diakonos begins DOC1021 melanoma dosing as its outpatient cell therapy challenges intensive treatment and tests patient-specific manufacturing.